Please activate JavaScript!
Please install Adobe Flash Player, click here for download

Cloettapreis_2004_Nr_32

9. Buckee C.O., Koelle K., Mustard M.J., Gupta S., 2004. The effects of host contact network structure on pathogen diversity and strain structure. Proc. Natl. Acad. Sci. U. S. A 101:10839–10844. 10. Butticaz C., Ciuffi A., Munoz M., Thomas J., Bridge A., Pebernard S., Iggo R., Meylan P., Telenti A., 2003. Protection from HIV-1 infection fo primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression. Antivir. Ther. 8:373–377. 11. Carrillo A., Stewart K.D., Sham H.L., Norbeck D.W., Kohlbrenner W.E., Leonard J.M., Kempf D.J., Molla A., 1998. In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor. J Virol 72:7532–7541. 12. Carrington M., Nelson G., O’Brien S.J., 2001. Considering genetic profiles in func- tional studies of immune responsiveness to HIV-1. Immunol. Lett. 79:131–140. 13. Chang J., Naif H.M., Li S., Sullivan J.S., Randle C.M., Cunningham A.L., 1996. Twin studies demonstrate a host cell genetic effect on productive human immuno- deficiency virus infection of human monocytes and macrophages in vitro. J. Virol. 70:7792–7803. 14. Cheung V.G., Conlin L.K., Weber T.M., Arcaro M., Jen K.Y., Morley M., Spielman R.S., 2003. Natural variation in human gene expression assessed in lymphoblastoid cells. Nat. Genet. 33:422–425. 15. Ciuffi A., Bleiber G., Munoz M., Martinez R., Loeuillet C., Rehr M., Fischer M., Gunthard H., Oxenius A., Meylan P., Bonhoeffer S., Trono D., Telenti A., 2004. Entry and transcription as key determinants of differences in CD4 T cell permissive- ness to HIV-1 infection. J Virol 78:10747–10754. 16. Cox N.J., 2004. Human genetics: an expression of interest. Nature 430:733–734. 17. Croteau G., Doyon L., Thibeault D., McKercher G., Pilote L., Lamarre D., 1997. Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J Virol 71:1089–1096. 18. Dausset J., Cann H., Cohen D., Lathrop M., Lalouel J.M., White R., 1990. Centre d’etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics 6:575–577. 19. Doyon L., Croteau G., Thibeault D., Poulin F., Pilote L., Lamarre D., 1996. Second locus involved in human immunodeficiency virus type 1 resistance to protease inhib- itors. J Virol 70:3763–3769. 26

Seitenübersicht